Drug Shortage Report for DUREZOL
| Report ID | 152583 |
| Drug Identification Number | 02415534 |
| Brand name | DUREZOL |
| Common or Proper name | DUREZOL .05% EMUL 5ML TRD |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DIFLUPREDNATE |
| Strength(s) | 0.05% |
| Dosage form(s) | EMULSION |
| Route of administration | OPHTHALMIC OPHTHALMIC |
| Packaging size | 5ML |
| ATC code | S01BA |
| ATC description | ANTIINFLAMMATORY AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2023-02-28 |
| Actual start date | 2023-02-25 |
| Estimated end date | Unknown |
| Actual end date | 2023-03-23 |
| Shortage status | Resolved |
| Updated date | 2024-04-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v13 | 2024-04-05 | English | Compare |
| v12 | 2023-04-13 | French | Compare |
| v11 | 2023-04-13 | English | Compare |
| v10 | 2022-10-25 | English | Compare |
| v9 | 2022-10-21 | English | Compare |
| v8 | 2022-10-20 | French | Compare |
| v7 | 2022-10-20 | English | Compare |
| v6 | 2022-03-03 | French | Compare |
| v5 | 2022-03-03 | English | Compare |
| v4 | 2022-03-01 | English | Compare |
| v3 | 2022-01-12 | French | Compare |
| v2 | 2022-01-12 | English | Compare |
| v1 | 2022-01-12 | English | Compare |
Showing 1 to 13 of 13